financetom
Business
financetom
/
Business
/
Axos Financial Refutes Short-Seller Claims Commercial Real Estate Portfolio Poses Higher Risk
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Axos Financial Refutes Short-Seller Claims Commercial Real Estate Portfolio Poses Higher Risk
Jun 4, 2024 2:12 PM

04:56 PM EDT, 06/04/2024 (MT Newswires) -- Axos Financial ( AX ) responded to short-seller Hindenburg Research's accusations Tuesday, rejecting assertions it is courting potential problems through its recent embrace of commercial real estate loans.

In a regulatory filing, Axos said the Hindenburg report includes "inaccuracies and innuendo" the present a distorted view of its loan portfolio. The bank said its largest CRE portfolio called Specialty had roughly $5.22 billion in loans at the end of March and that its financial partners provide considerable protection should borrowers run into problems in repayments.

Hindenburg also misstated the size of its commercial real estate portfolio, failing to mention several loans that have been repaid since Q1. The short-seller also overstated how large a share commercial real estate loans comprise overall.

Axos shares were off 1% in extended session, after closing regular trading more than 4% lower.

Price: 49.64, Change: -0.61, Percent Change: -1.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Teads Appoints Mollie Spilman as Chief Commercial Officer
Teads Appoints Mollie Spilman as Chief Commercial Officer
Nov 6, 2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teads, the omnichannel outcomes platform for the open internet, today announced the appointment of Mollie Spilman as Chief Commercial Officer (CCO), effective November 10. She will oversee global commercial strategy and execution, working closely with regional leadership and key partners to accelerate growth and deepen client performance for marketers, agencies and content...
Novo, Lilly shares rise as Trump obesity drug deal nears
Novo, Lilly shares rise as Trump obesity drug deal nears
Nov 6, 2025
Nov 6 (Reuters) - Shares of obesity drugmakers Eli Lilly ( LLY ) and Novo Nordisk rose early on Thursday in anticipation of a White House deal that would reduce prices of their blockbuster weight-loss treatments in return for expanded market access. Denmark's Novo, which is also locked in a bidding war with Pfizer ( PFE ) over U.S. obesity...
BeOne Medicines Q3 Adjusted Earnings, Revenue Rise; Lifts Lower-End of Fiscal 2025 Revenue Outlook Range
BeOne Medicines Q3 Adjusted Earnings, Revenue Rise; Lifts Lower-End of Fiscal 2025 Revenue Outlook Range
Nov 6, 2025
06:31 AM EST, 11/06/2025 (MT Newswires) -- BeOne Medicines ( ONC ) reported Q3 adjusted earnings Thursday of $2.65 per diluted American depositary share, up from $0.48 a year earlier. Analyst estimates were not readily available for comparison. Total revenue for the quarter ended Sept. 30 was $1.41 billion, up from $1 billion a year earlier. Analysts surveyed by FactSet...
Snap shares surge as $400 million Perplexity deal rekindles AI ambitions
Snap shares surge as $400 million Perplexity deal rekindles AI ambitions
Nov 6, 2025
(Reuters) -Snap shares jumped 18% in premarket trading on Thursday after its $400 million partnership with startup Perplexity AI reassured investors that the social media company could catch up to larger rivals in the artificial intelligence race. The Snapchat parent's shares had risen 16% after market hours on Wednesday following the news. Perplexity's artificial intelligence-powered search engine will be integrated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved